Problems in Blood Drug Lead to Halt by Factory
52205
A major maker of heparin, a blood thinner used widely in surgery and dialysis, has stopped making it after hundreds of patients reported severe allergic reactions to the drug.
121380
THE future of AstraZenecaâs blood-thinning medicine, Exanta, was thrown into fresh doubt last night after Franceâs leading drugs regulator confirmed that it was reviewing the medicineâs approval status.
423522
U.S. health officials said Wednesday they have not inspected a Chinese factory that may be a source of problems with a blood thinner linked to allergic reactions and four deaths, but plan an inspection as soon as possible
202825
The Food and Drug Administration knew of problems at the Chiron factory in Liverpool, England where half of the flu vaccine headed to the United States was being produced, but did next to nothing about it until the plant shut down according to a report
667330
Business & money: Europe's largest drugmaker blames safety concerns over its Avandia diabetes pill
174211
A drug manufacturer has been found to infringe patents licensed by the maker of a rival drug.
510472
Nearly everyone seemed to have been caught off-guard last month when a British flu vaccine manufacturer was closed down by authorities because of contamination that was discovered at the company&#39;s Liverpool plant.
189363
China's efforts to clean up an unsafe blood supply chain, blamed for many HIV infections, has led to a severe shortage of an effective hemophilia drug and put tens of thousands of patients in danger.
34507
ATLANTA -- The government has halted a national sickle-cell study because two children suffered strokes and more than a dozen others developed dangerous conditions that put them at high risk of having a stroke.
589276
U.S. regulators on Tuesday ordered companies to stop selling unapproved drugs containing quinine, which is approved only in one anti-malaria drug and can have serious side-effects.
767331
Biopharma firm ends trials for a promising drug and offloads four commercial products.
407294
The biotech company announces new drug delays.
98642
A study aimed at determining if some children with sickle cell anemia could be weaned off blood transfusion therapy has been halted because two young patients who stopped getting the procedure suffered strokes and others developed a high chance of strokes.
455403
The biopharma announces a dramatic shift following the failure of its lead drug.
37552
The drug giant Merck suspends trials on an HIV vaccine that was regarded as one of the most promising.
159683
The company that makes half the flu vaccine used in the U.S. was suspended for manufacturing problems.
188062
THURSDAY, Jan. 24 (HealthDay News) -- A study of the new anti-clotting drug idraparinux for preventing strokes was stopped early because of excess bleeding, a problem that has plagued the medication.